Oral administration of D-glucosamine confers broad-spectrum protection against human coronaviruses including SARS-CoV-2

• Qi Qi,
• Qi Chen,
• Yumei Dong,
• Kun Wang,
• Jialu Wang,
• Guiming Jin,
• Aiping Zheng,
• Rong Zhang,
• Yongqiang Deng,
• Yuhuan Li,
• Chengfeng Qin,
• Xiaotao Duan

Affiliations

Qi Qi

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology

Qi Chen

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology

Yumei Dong

General Hospital of PLA Central Theater Command Department of Disease Prevention and Control

Kun Wang

Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College

Jialu Wang

General Hospital of PLA Central Theater Command Department of Disease Prevention and Control

Guiming Jin

General Hospital of PLA Central Theater Command Department of Disease Prevention and Control

Aiping Zheng

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology

Rong Zhang

School of Basic Medical Sciences, Fudan University

Yongqiang Deng

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology

Yuhuan Li

Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College

Chengfeng Qin

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology

Xiaotao Duan

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology